JP2018526994A5 - - Google Patents

Download PDF

Info

Publication number
JP2018526994A5
JP2018526994A5 JP2018510981A JP2018510981A JP2018526994A5 JP 2018526994 A5 JP2018526994 A5 JP 2018526994A5 JP 2018510981 A JP2018510981 A JP 2018510981A JP 2018510981 A JP2018510981 A JP 2018510981A JP 2018526994 A5 JP2018526994 A5 JP 2018526994A5
Authority
JP
Japan
Prior art keywords
raav
epo
sequence
promoter
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018510981A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018526994A (ja
JP6877408B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/049487 external-priority patent/WO2017040524A1/en
Publication of JP2018526994A publication Critical patent/JP2018526994A/ja
Publication of JP2018526994A5 publication Critical patent/JP2018526994A5/ja
Application granted granted Critical
Publication of JP6877408B2 publication Critical patent/JP6877408B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018510981A 2015-08-31 2016-08-30 ペット治療用aav−epo Active JP6877408B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562212144P 2015-08-31 2015-08-31
US62/212,144 2015-08-31
US201662336211P 2016-05-13 2016-05-13
US62/336,211 2016-05-13
PCT/US2016/049487 WO2017040524A1 (en) 2015-08-31 2016-08-30 Aav-epo for treating companion animals

Publications (3)

Publication Number Publication Date
JP2018526994A JP2018526994A (ja) 2018-09-20
JP2018526994A5 true JP2018526994A5 (enExample) 2019-09-26
JP6877408B2 JP6877408B2 (ja) 2021-05-26

Family

ID=58188403

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018510981A Active JP6877408B2 (ja) 2015-08-31 2016-08-30 ペット治療用aav−epo

Country Status (9)

Country Link
US (2) US11117942B2 (enExample)
EP (1) EP3344650B1 (enExample)
JP (1) JP6877408B2 (enExample)
KR (1) KR20180057636A (enExample)
CN (1) CN108137664B (enExample)
AU (1) AU2016315699B2 (enExample)
CA (1) CA2995733A1 (enExample)
HK (1) HK1257024A1 (enExample)
WO (1) WO2017040524A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3676385A1 (en) * 2017-07-06 2020-07-08 The Trustees of The University of Pennsylvania Aav9-mediated gene therapy for treating mucopolysaccharidosis type i
TW202039857A (zh) 2018-07-27 2020-11-01 美商銳進科斯生物股份有限公司 黏多醣病iva之治療
US20220025005A1 (en) * 2018-12-12 2022-01-27 Kindred Biosciences, Inc. Erythropoietin Analogs For Veterinary Use
WO2022067080A1 (en) * 2020-09-28 2022-03-31 Scout Bio, Inc. Composition and uses thereof
EP4284335A1 (en) 2021-02-01 2023-12-06 RegenxBio Inc. Gene therapy for neuronal ceroid lipofuscinoses
IL311096A (en) 2021-08-31 2024-04-01 Scout Bio Inc Antigen binding molecules and their uses

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5436146A (en) 1989-09-07 1995-07-25 The Trustees Of Princeton University Helper-free stocks of recombinant adeno-associated virus vectors
US6268213B1 (en) 1992-06-03 2001-07-31 Richard Jude Samulski Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
US5869305A (en) 1992-12-04 1999-02-09 The University Of Pittsburgh Recombinant viral vector system
US5478745A (en) 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
US6204059B1 (en) 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
US6093570A (en) 1995-06-07 2000-07-25 The University Of North Carolina At Chapel Hill Helper virus-free AAV production
US5741683A (en) 1995-06-07 1998-04-21 The Research Foundation Of State University Of New York In vitro packaging of adeno-associated virus DNA
US5846528A (en) * 1996-01-18 1998-12-08 Avigen, Inc. Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
AU728220B2 (en) 1997-04-14 2001-01-04 Cell Genesys, Inc. Methods for increasing the efficiency of recombinant AAV product
US6696411B1 (en) * 1998-04-22 2004-02-24 Cornell Research Foundation, Inc. Canine erythropoietin gene and recombinant protein
EP1080218A1 (en) 1998-05-27 2001-03-07 University of Florida Method of preparing recombinant adeno-associated virus compositions by using an iodixanol gradient
JP2002525047A (ja) * 1998-09-16 2002-08-13 ネクシア バイオテクノロジーズ, インコーポレイテッド 尿における組換え蛋白質の産生
ATE454445T1 (de) 1998-11-10 2010-01-15 Univ North Carolina Virusvektoren und verfahren für ihre herstellung und verabreichung.
CA2288341C (en) * 1998-12-17 2005-01-04 Pfizer Products Inc. Erythropoietin in the treatment of domestic and livestock animals for anemia
EP1520589A1 (en) * 1998-12-17 2005-04-06 Pfizer Products Inc. Erythropoietin in the treatment of domestic and livestock animals for anaemia
EP2369002A1 (en) 1999-08-09 2011-09-28 Targeted Genetics Corporation Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs
CA2410901C (en) 2000-06-01 2012-03-20 University Of North Carolina At Chapel Hill Methods and compounds for controlled release of recombinant parvovirus vectors
SG10202108118RA (en) 2001-11-13 2021-08-30 Univ Pennsylvania A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
ES2975413T3 (es) 2001-12-17 2024-07-05 Univ Pennsylvania Secuencias de serotipo 8 de virus adenoasociado (AAV), vectores que las contienen y usos de las mismas
US20070015238A1 (en) 2002-06-05 2007-01-18 Snyder Richard O Production of pseudotyped recombinant AAV virions
HUE054805T2 (hu) 2003-09-30 2021-09-28 Univ Pennsylvania Adeno-asszociált vírus (AAV) kládok, szekvenciák, az azokat tartalmazó vektorok és alkalmazásaik
EP3085389A1 (en) * 2005-04-07 2016-10-26 The Trustees Of The University Of Pennsylvania Method of increasing the function of an aav vector
US9988427B2 (en) * 2005-05-13 2018-06-05 Charite Universitaetsmedizen-Berlin Erythropoietin variants
EP1736481A1 (en) * 2005-05-13 2006-12-27 Charite Universitätsmedizin-Berlin Erythropoietin variants
WO2006132118A1 (ja) 2005-06-09 2006-12-14 Matsushita Electric Industrial Co., Ltd. 振幅誤差補償装置及び直交度誤差補償装置
WO2007120542A2 (en) 2006-03-30 2007-10-25 The Board Of Trustees Of The Leland Stanford Junior University Aav capsid library and aav capsid proteins
WO2010011642A2 (en) 2008-07-21 2010-01-28 The Trustees Of The University Of Pennsylvania Methods and compositions using splicing regulatory proteins involved in tumor suppression
PL2342223T3 (pl) * 2008-09-26 2017-09-29 Ambrx, Inc. Zmodyfikowane polipeptydy zwierzęcej erytropoetyny i ich zastosowania
JP5879256B2 (ja) 2009-05-02 2016-03-08 ジェンザイム・コーポレーション 神経変性障害のための遺伝子治療
KR20130040844A (ko) 2010-03-29 2013-04-24 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 약학적으로 유발된 전이유전자 제거 시스템
US9315825B2 (en) 2010-03-29 2016-04-19 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
FR2977562B1 (fr) 2011-07-06 2016-12-23 Gaztransport Et Technigaz Cuve etanche et thermiquement isolante integree dans une structure porteuse
EP2900275A4 (en) * 2012-09-29 2016-05-25 Univ Pennsylvania VETERINARY COMPOSITION AND METHOD FOR NONOPERATIVE CASTRATION
WO2015012924A2 (en) 2013-04-29 2015-01-29 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and use thereof
EP2994483A4 (en) * 2013-05-06 2017-02-08 Cell Machines, Inc. Methods and compositions related to large scale production of proteins

Similar Documents

Publication Publication Date Title
US20220331409A1 (en) Factor ix gene therapy
JP2018537984A5 (enExample)
JP2020514286A5 (enExample)
JP2017518271A5 (enExample)
JP2020537542A5 (enExample)
JP2016512683A5 (enExample)
JP2019089787A5 (enExample)
JP2020537543A5 (enExample)
JP2019513794A5 (enExample)
RU2018125468A (ru) Генная терапия офтальмологических нарушений
IL278213B1 (en) A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd)
RU2018136611A (ru) Генная терапия для лечения гемофилии a
JP2019530463A5 (enExample)
JP2015523379A5 (enExample)
RU2020137429A (ru) Лечение пигментного ретинита
JP2020073536A5 (enExample)
JP2021507687A5 (enExample)
JP2018526003A (ja) イヌの癌を治療するためのキメラaav−抗vegf
JP2019523648A5 (enExample)
JP2022531861A5 (enExample)
RU2019100525A (ru) Векторная система на основе аденоассоциированного вируса
JP2020512822A5 (enExample)
JP2017529395A5 (enExample)
JP2021508241A5 (enExample)
JP2021502978A5 (enExample)